Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

被引：0
|
作者：
Chiao-En Wu
Ching-Fu Chang
Chen-Yang Huang
Cheng-Ta Yang
Chih-Hsi Scott Kuo
Ping-Chih Hsu
John Wen-Cheng Chang
机构：
[1] Chang Gung University College of Medicine,Department of Internal Medicine, Division of Hematology
[2] Chang Gung University College of Medicine,Oncology, Chang Gung Memorial Hospital at Linkou
来源：
BMC Cancer | / 21卷
关键词：
Lung cancer; Afatinib; EGFR; TKI; Performance status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Metastatic non-small-cell lung cancer with EGFR mutation - case report
    Jasiowka, Marek
    Cedrych, Ida
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : G46 - G48
  • [42] Successful afatinib treatment of advanced non-small-cell lung cancer patients undergoing hemodialysis
    Imai, Hisao
    Kaira, Kyoichi
    Naruse, Ichiro
    Hayashi, Hideki
    Iihara, Hirotoshi
    Kita, Yutaro
    Mizusaki, Naoki
    Asao, Takayuki
    Itoh, Yoshinori
    Sugiyama, Tadashi
    Minato, Koichi
    Yamada, Masanobu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 209 - 213
  • [43] Novel EGFR Inhibitors in Non-small Cell Lung Cancer: Current Status of Afatinib
    Liao, Bin-Chi
    Lin, Chia-Chi
    Yang, James Chih-Hsin
    CURRENT ONCOLOGY REPORTS, 2017, 19 (01)
  • [44] Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter retrospective SEQUENCE study
    Chang, Gee-Chen
    Tseng, Chien-Hua
    Hsu, Kuo-Hsuan
    Yu, Chong-Jen
    Yang, Cheng-Ta
    Chen, Kun-Chieh
    Yang, Tsung-Ying
    Tseng, Jeng-Sen
    Liu, Chien-Ying
    Liao, Wei-Yu
    Hsia, Te-Chun
    Tu, Chih-Yen
    Lin, Meng-Chih
    Tsai, Ying-Huang
    Hsieh, Meng-Jer
    Wu, Wen-Shuo
    Chen, Yuh-Min
    LUNG CANCER, 2017, 104 : 58 - 64
  • [45] Efficacy and Safety of Icotinib in Advanced Non-Small-Cell Lung Cancer Patients Harboring Uncommon EGFR Mutation: a Retrospective Analysis
    Yuan, Xiaobin
    Wang, Yang
    Yang, Min
    Shen, Zhilin
    Chen, Hui
    He, Xiangbo
    Ma, Yongbin
    Ding, Lieming
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (01): : 46 - 53
  • [46] Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer
    Park, Keunchil
    Bennouna, Jaafar
    Boyer, Michael
    Hida, Toyoaki
    Hirsh, Vera
    Kato, Terufumi
    Lug, Shun
    Mok, Tony
    Nakagawa, Kazuhiko
    O'Byrne, Kenneth
    Paz-Ares, Luis
    Schuler, Martin
    Sibilotru, Denis Moro
    Tan, Eng-Huat
    Tanaka, Hiroshi
    We, Yi-Long
    Yang, James C-H
    Zhang, Li
    Zhou, Caicun
    Maerten, Angela
    Tang, Wenbo
    Yamamoto, Nobuyuki
    LUNG CANCER, 2019, 132 : 126 - 131
  • [47] Nivolumab for Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer
    Yoshida, H.
    Kim, Y. H.
    Ozasa, H.
    Nagai, H.
    Sakamori, Y.
    Tsuji, T.
    Nomizo, T.
    Funazo, T.
    Yasuda, Y.
    Hirai, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2416 - S2416
  • [48] Treatment of Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in Clinical Practice
    Yamada, Yutaka
    Tamura, Tomohiro
    Yamamoto, Yusuke
    Ichimura, Hideo
    Hayashihara, Kenji
    Saito, Takefumi
    Yamada, Hideyasu
    Endo, Takeo
    Nakamura, Ryota
    Inage, Yoshihisa
    Satoh, Hiroaki
    Iguchi, Kesato
    Saito, Kazuto
    Inagaki, Masaharu
    Kikuchi, Norihiro
    Kurishima, Koichi
    Ishikawa, Hiroichi
    Sakai, Mitsuaki
    Kamiyama, Koichi
    Shiozawa, Toshihiro
    Hizawa, Nobuyuki
    Sekine, Ikuo
    Sato, Yukio
    Funayama, Yasunori
    Miyazaki, Kunihiko
    Kodama, Takahide
    Hayashi, Shigen
    Nomura, Akihiro
    Nakamura, Hiroyuki
    Furukawa, Kinya
    Yamashita, Takaaki
    Okubo, Hatsumi
    Suzuki, Hisashi
    Kiyoshima, Moriyuki
    Kaburagi, Takayuki
    ANTICANCER RESEARCH, 2020, 40 (10) : 5757 - 5764
  • [49] Comparison of Afatinib Versus Erlotinib for Advanced Non-Small-Cell Lung Cancer Patients with Resistance to EGFR-TKI
    Sakamori, Y.
    Yasuda, Y.
    Funazo, T.
    Nomizo, T.
    Tsuji, T.
    Yoshida, H.
    Nagai, H.
    Ozasa, H.
    Hirai, T.
    Kim, Y. H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2396 - S2396
  • [50] Novel EGFR Inhibitors in Non-small Cell Lung Cancer: Current Status of Afatinib
    Bin-Chi Liao
    Chia-Chi Lin
    James Chih-Hsin Yang
    Current Oncology Reports, 2017, 19
12345